Dyadic International Inc, DE

DYAINASDAQ · USD
0.29USD0.00 (-7.66%)
132

Dyadic International Inc, DE (DYAI) Implied Volatility Current

DYAI's 30 day implied volatility is 705.66%, with an IV Rank of 75.79%. This is a high IV Rank versus the past year, meaning Dyadic International Inc, DE options are relatively expensive and currently favor sellers. DYAI's 30 day historical volatility sits at 79.59%, which means implied volatility is running 626.07 points above historical volatility, as of Nov 20, 2026.

Read more

Tracking DYAI implied volatility helps you spot when Dyadic International Inc, DE options are historically cheap or expensive, and where the best trades are hiding. When DYAI IV rises, premiums increase and sellers get more attractive pricing, and when it drops, buyers find cheaper contracts. Use our scanner to monitor DYAI implied volatility current levels in real time and filter for high probability trades.

Implied volatility is derived from option prices and represents the annualized expected move of a stock. Tracking DYAI IV rank helps you see whether DYAI's implied volatility is historically high or low, since IV rank compares today's reading against the past year's range. A high rank signals relatively expensive premiums and tends to favor sellers, a low rank signals relatively cheap premiums and tends to favor buyers.

Dyadic International, Inc., a biotechnology platform company, develops, produces, and sells enzymes and other proteins in the United States. The company utilizes its patented and proprietary C1 platform and other technologies to conduct research, development, and commercial activities for the development and manufacturing of human and animal vaccines and drugs, such as virus like particles and antigens, monoclonal antibodies, bi/tri-specific antibodies, fab antibody fragments, Fc-fusion proteins, biosimilars and/or biobetters, and other therapeutic enzymes and proteins. It offers DYAI-100, SARS-CoV-2-RBD antigen vaccine candidate towards a first-in-human Phase 1 clinical trial, is to validate to serve as proof of concept for the development of next generation multivariant COVID-19 vaccine candidates.

Implied Volatility

IV Rank
75.79%IV Rank
High

IV is highly elevated. Premiums are expensive, strongly favoring sellers.

Implied Volatility (30d)705.66%

IV Rank75.79%

Historical Volatility (30d)79.59%

IV Minus HV+626.07%

As of Nov 20, 2026

Prices move. This one stays.Lock in 5 years at a special price and save $1,503. Ending soon.See the Black Friday deal →